StockFame
  • Trending News
  • Markets
  • US Markets
  • Indian Stocks
  • Economics
  • Crypto News
Select Page

Inside Cipla’s battle with ‘superbugs’ as antibiotic resistance rises in India

by Live mint | July 3, 2025 4:06 pm | Indian Stocks, Market, News

‘Superbugs’ render existing treatments ineffective and can worsen an infection, even causing death.

Recent Posts

  • Breaking Barriers: XRP Mining’s Innovative App Opens Global Access to Secure Cloud Mining
  • Aeries Technology Announces Completion of Fiscal Year 2025 Earnings Call
  • BUTLER NATIONAL CORPORATION ANNOUNCES FISCAL YEAR END 2025 FINANCIAL RESULTS
  • Amber International Raises $25.5M to Expand $100M Crypto Reserve Strategy
  • A Majority of Companies Are Already Feeling the Climate Heat

About Stockfame

Stockfame is a global media platform delivering bold insights on business, markets, technology, leadership, and entrepreneurship. We bring you research-backed news and sharp analysis to help you stay ahead of the curve.

Quick News Links

  • Crypto News
  • Indian Stocks
  • Latest Posts
  • Market
  • News
  • Trending News
  • US Markets

Contact Us

Reach out to us at:
Phone:  [+91] 9834938257
Email: contact@stockfame.com
For Advertisement, Press Releases, Partnerships or to get backlinks on this website, please e-mail us at contact@stockfame.com

Quick Reads

  • Global market news
  • Crypto Market News
  • Indian Market News
  • Economy News
  • Latest Business News
  • About
  • Terms and Conditions
  • Privacy Policy
  • Website User Agreement
  • Disclaimer
  • Facebook
  • X
  • Instagram
  • RSS
Copyright @StockFame | All Rights Reserved